Impact of pathological stage and histological subtype on clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral uracil–tegafur for non-small cell lung cancer: subanalysis of SLCG0401 trial

2019 ◽  
Vol 24 (11) ◽  
pp. 1367-1376 ◽  
Author(s):  
Junichi Soh ◽  
Shinichi Toyooka ◽  
Norihito Okumura ◽  
Hiroshige Nakamura ◽  
Masao Nakata ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Adjuvant Chemotherapy ◽  
Clinical Outcome ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Histological Subtype ◽  
Pathological Stage ◽  
Small Cell Lung

scholarly journals Safety of Adjuvant Chemotherapy with Carboplatin and Weekly Paclitaxel for Pathological Stage IB-IIIB Non-small Cell Lung Cancer

Haigan ◽  
2011 ◽  
Vol 51 (3) ◽  
pp. 165-170 ◽  
Author(s):  
Yoshio Okano ◽  
Hiroyuki Hino ◽  
Mitsuteru Yoshida ◽  
Nobuo Hatakeyama ◽  
Tsutomu Shinohara ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Adjuvant Chemotherapy ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Weekly Paclitaxel ◽  
Pathological Stage ◽  
Small Cell Lung ◽  
Stage Ib

scholarly journals Heterogeneous prognosis and adjuvant chemotherapy in pathological stage I non-small cell lung cancer patients

2015 ◽  
Vol 6 (5) ◽  
pp. 620-628 ◽  
Author(s):  
Chia-Hsin Liu ◽  
Yi-Jen Peng ◽  
Hong-Hau Wang ◽  
Ying-Chieh Chen ◽  
Chen-Liang Tsai ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Adjuvant Chemotherapy ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Stage I ◽  
Pathological Stage ◽  
Small Cell Lung ◽  
Lung Cancer Patients

Adjuvant chemotherapy for high-risk pathological stage I non-small cell lung cancer

2021 ◽  
Author(s):  
Yasuhiro Tsutani ◽  
Kentaro Imai ◽  
Hiroyuki Ito ◽  
Yoshihiro Miyata ◽  
Norihiko Ikeda ◽  
...  
Keyword(s):  
Lung Cancer ◽  
High Risk ◽  
Adjuvant Chemotherapy ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Stage I ◽  
Pathological Stage ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document